A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000) (Englisch)
- Neue Suche nach: Delbaldo, C.
- Neue Suche nach: Serin, D.
- Neue Suche nach: Mousseau, M.
- Neue Suche nach: Greget, S.
- Neue Suche nach: Audhuy, B.
- Neue Suche nach: Priou, F.
- Neue Suche nach: Berdah, J.F.
- Neue Suche nach: Teissier, E.
- Neue Suche nach: Laplaige, P.
- Neue Suche nach: Zelek, L.
- Neue Suche nach: Delbaldo, C.
- Neue Suche nach: Serin, D.
- Neue Suche nach: Mousseau, M.
- Neue Suche nach: Greget, S.
- Neue Suche nach: Audhuy, B.
- Neue Suche nach: Priou, F.
- Neue Suche nach: Berdah, J.F.
- Neue Suche nach: Teissier, E.
- Neue Suche nach: Laplaige, P.
- Neue Suche nach: Zelek, L.
In:
EUROPEAN JOURNAL OF CANCER -A-
;
50
, 1
;
23-30
;
2014
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC100) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)
-
Beteiligte:Delbaldo, C. ( Autor:in ) / Serin, D. ( Autor:in ) / Mousseau, M. ( Autor:in ) / Greget, S. ( Autor:in ) / Audhuy, B. ( Autor:in ) / Priou, F. ( Autor:in ) / Berdah, J.F. ( Autor:in ) / Teissier, E. ( Autor:in ) / Laplaige, P. ( Autor:in ) / Zelek, L. ( Autor:in )
-
Erschienen in:EUROPEAN JOURNAL OF CANCER -A- ; 50, 1 ; 23-30
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2014
-
Format / Umfang:8 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 616.994
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 616.994 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 50, Ausgabe 1
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 1.e1
-
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectumvan de Velde, C.J.H. / Boelens, P.G. / Borras, J.M. / Coebergh, J.-W. / Cervantes, A. / Blomqvist, L. / Beets-Tan, R.G.H. / van den Broek, C.B.M. / Brown, G. / Van Cutsem, E. et al. | 2014
- 23
-
A phase III adjuvant randomised trial of 6 cycles of 5-fluorouracil-epirubicine-cyclophosphamide (FEC"1"0"0) versus 4 FEC 100 followed by 4 Taxol (FEC-T) in node positive breast cancer patients (Trial B2000)Delbaldo, C. / Serin, D. / Mousseau, M. / Greget, S. / Audhuy, B. / Priou, F. / Berdah, J. F. / Teissier, E. / Laplaige, P. / Zelek, L. et al. | 2014
- 31
-
Impact of the transition from screen-film to digital screening mammography on interval cancer characteristics and treatment - A population based study from the NetherlandsNederend, J. / Duijm, L. E. M. / Louwman, M. W. J. / Coebergh, J. W. / Roumen, R. M. H. / Lohle, P. N. / Roukema, J. A. / Rutten, M. J. C. M. / van Steenbergen, L. N. / Ernst, M. F. et al. | 2014
- 40
-
A systematic review of cost-effectiveness of monoclonal antibodies for metastatic colorectal cancerLange, A. / Prenzler, A. / Frank, M. / Kirstein, M. / Vogel, A. / von der Schulenburg, J.M. et al. | 2014
- 50
-
Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown originThomassen, I. / Verhoeven, R. H. A. / van Gestel, Y. R. B. M. / van de Wouw, A. J. / Lemmens, V. E. P. P. / de Hingh, I. H. J. T. et al. | 2014
- 57
-
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancerLoupakis, F. / Cremolini, C. / Salvatore, L. / Masi, G. / Sensi, E. / Schirripa, M. / Michelucci, A. / Pfanner, E. / Brunetti, I. / Lupi, C. et al. | 2014
- 64
-
Small tumour size is associated with new-onset chronic kidney disease after radical nephrectomy in patients with renal cell carcinomaJeon, H.G. / Choo, S.H. / Sung, H.H. / Jeong, B.C. / Seo, S.I. / Jeon, S.S. / Choi, H.-Y. / Lee, H.M. et al. | 2014
- 70
-
Adjuvant 5-flurouracil, alpha-interferon and interleukin-2 versus observation in patients at high risk of recurrence after nephrectomy for renal cell carcinoma: Results of a Phase III randomised European Organisation for Research and Treatment of Cancer (Genito-Urinary Cancers Group)/National Cancer Research Institute trialAitchison, M. / Bray, C.A. / Van Poppel, H. / Sylvester, R. / Graham, J. / Innes, C. / McMahon, L. / Vasey, P.A. et al. | 2014
- 78
-
Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abirateroneBianchini, D. / Lorente, D. / Rodriguez-Vida, A. / Omlin, A. / Pezaro, C. / Ferraldeschi, R. / Zivi, A. / Attard, G. / Chowdhury, S. / de Bono, J. S. et al. | 2014
- 85
-
Chromosomal gains and losses in human papillomavirus-associated neoplasia of the lower genital tract - A systematic review and meta-analysisThomas, L. K. / Bermejo, J. L. / Vinokurova, S. / Jensen, K. / Bierkens, M. / Steenbergen, R. / Bergmann, M. / von Knebel Doeberitz, M. / Reuschenbach, M. et al. | 2014
- 99
-
Cyclin E1 (CCNE1) as independent positive prognostic factor in advanced stage serous ovarian cancer patients - A study of the OVCAD consortiumPils, D. / Bachmayr-Heyda, A. / Auer, K. / Svoboda, M. / Auner, V. / Hager, G. / Obermayr, E. / Reiner, A. / Reinthaller, A. / Speiser, P. et al. | 2014
- 111
-
The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patientsvan der Ploeg, A. P. T. / van Akkooi, A. C. J. / Haydu, L. E. / Scolyer, R. A. / Murali, R. / Verhoef, C. / Thompson, J. F. / Eggermont, A. M. M. et al. | 2014
- 121
-
Efficacy and safety of ipilimumab 3 mg/kg in patients with pretreated, metastatic, mucosal melanomaDel Vecchio, M. / Di Guardo, L. / Ascierto, P.A. / Grimaldi, A.M. / Sileni, V.C. / Pigozzo, J. / Ferraresi, V. / Nuzzo, C. / Rinaldi, G. / Testori, A. et al. | 2014
- 128
-
Primary cardiac sarcomas: A retrospective study of the French Sarcoma GroupIsambert, N. / Ray-Coquard, I. / Italiano, A. / Rios, M. / Kerbrat, P. / Gauthier, M. / Blouet, A. / Chaigneau, L. / Duffaud, F. / Piperno-Neumann, S. et al. | 2014
- 137
-
Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenaseChoi, S. A. / Lee, J. Y. / Phi, J. H. / Wang, K. C. / Park, C. K. / Park, S. H. / Kim, S. K. et al. | 2014
- 150
-
Quantitative and qualitative analysis of study-related patient information sheets in randomised neuro-oncology phase III-trialsReinert, C. / Kremmler, L. / Burock, S. / Bogdahn, U. / Wick, W. / Gleiter, C.H. / Koller, M. / Hau, P. et al. | 2014
- 159
-
The NF-@kB pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient's samplesCamara-Clayette, V. / Lecluse, Y. / Schrader, C. / Klapper, W. / Vainchenker, W. / Hermine, O. / Ribrag, V. et al. | 2014
- 159
-
The NF- kappa B pathway is rarely spontaneously activated in mantle cell lymphoma (MCL) cell lines and patient's samplesCamara-Clayette, V. / Lecluse, Y. / Schrader, C. / Klapper, W. / Vainchenker, W. / Hermine, O. / Ribrag, V. et al. | 2014
- 170
-
Phase II study of temozolomide in combination with topotecan (TOTEM) in relapsed or refractory neuroblastoma: A European Innovative Therapies for Children with Cancer-SIOP-European Neuroblastoma studyDi Giannatale, A. / Dias-Gastellier, N. / Devos, A. / Mc Hugh, K. / Boubaker, A. / Courbon, F. / Verschuur, A. / Ducassoul, S. / Malekzadeh, K. / Casanova, M. et al. | 2014
- 178
-
Treatment and prognostic factors in pleuropulmonary blastoma: An EXPeRT reportBisogno, G. / Brennan, B. / Orbach, D. / Stachowicz-Stencel, T. / Cecchetto, G. / Indolfi, P. / Bien, E. / Ferrari, A. / Dommange-Romero, F. et al. | 2014
- 185
-
Variation in detection of ductal carcinoma in situ during screening mammography: A survey within the International Cancer Screening NetworkLynge, E. / Ponti, A. / James, T. / Majek, O. / von Euler-Chelpin, M. / Anttila, A. / Fitzpatrick, P. / Frigerio, A. / Kawai, M. / Scharpantgen, A. et al. | 2014
- 193
-
Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: Evidence from a meta-analysis of 42 observational studiesZou, L. / Zhong, R. / Shen, N. / Chen, W. / Zhu, B. / Ke, J. / Lu, X. / Zhang, T. / Lou, J. / Wang, Z. et al. | 2014
- 193
-
Non-linear dose-response relationship between cigarette smoking and pancreatic cancer risk: Evidenc from a meta-analysis of 42 observational studiesZou, L. / Zhong, R. / Shen, N. / Chen, W. / Zhu, B. / Ke, J. / Lu, X. / Zhang, T. / Lou, J. / Wang, Z. et al. | 2014
- 204
-
Caveolin-1 promotes gastric cancer progression by up-regulating epithelial to mesenchymal transition by crosstalk of signalling mechanisms under hypoxic conditionKannan, A. / Krishnan, A. / Ali, M. / Subramaniam, S. / Halagowder, D. / Sivasithamparam, N. D. et al. | 2014
- 216
-
The multiple layers of non-genetic regulation of PTEN tumour suppressor activityCorreia, N.C. / Girio, A. / Antunes, I. / Martins, L.R. / Barata, J.T. et al. | 2014
- 226
-
Accurate detection of upper tract urothelial carcinoma in tissue and urine by means of quantitative GDF15, TMEFF2 and VIM promoter methylationMonteiro-Reis, S. / Leca, L. / Almeida, M. / Antunes, L. / Monteiro, P. / Dias, P.C. / Morais, A. / Oliveira, J. / Henrique, R. / Jeronimo, C. et al. | 2014
- 234
-
DNA vaccination against membrane-bound Kit ligand: A new approach to inhibiting tumour growth and angiogenesisOlgasi, C. / Dentelli, P. / Rosso, A. / Iavello, A. / Togliatto, G. / Toto, V. / Liberatore, M. / Barutello, G. / Musiani, P. / Cavallo, F. et al. | 2014
- 247
-
Talc used in anticancer drugs is promoter for diabetes in hepatocellular carcinoma induced ratsSingh, R. / Afzal, M. / Kazmi, I. / Anwar, F. et al. | 2014